Norway seeks to slow down any Omicron spread, government says




  • In US
  • 2021-11-29 11:57:07Z
  • By Reuters
 

OSLO (Reuters) -Norway will seek to limit any potential spread of the Omicron coronavirus variant, including by imposing longer isolation on those who are found to have been infected, the government said on Monday.

It is likely that Omicron will spread to Norway, although the virus variant has not yet been detected in the country, health authorities have said.

"The new virus variant underscores the need for rapid vaccination with first and second doses for those who have not received them, and a booster dose for those who are eligible," Health Minister Ingvild Kjerkol said in a statement.

In addition to longer isolation for those who are infected, members of the same household must also quarantine, while testing becomes mandatory for other close contacts, regardless of whether they are vaccinated or not, she said.

The government on Friday imposed restrictions on travellers from southern African nations where the new variant was first discovered.

(Reporting by Terje Solsvik, editing by Gwladys Fouche)

COMMENTS

More Related News

COVID Infection More Protective Than Vaccines Amid CA Delta Surge
COVID Infection More Protective Than Vaccines Amid CA Delta Surge

Those who were previously sick with COVID-19 had more protection from delta than the vaccinated, California health officials said.

'Completely full' ICUs as omicron wave stresses hospitals; FDA expands use of remdesivir. Latest COVID-19 updates

In Alabama, cases have soared and ICUs are full. Most of Vermont's hospitals face critical staffing levels, a study found. COVID-19 updates.

Striking new data shows vaccines have protected New Yorkers very well against Omicron so far
Striking new data shows vaccines have protected New Yorkers very well against Omicron so far

Data for the weeks ending January 1 and 8 showed that when infections spiked citywide, vaccinated New Yorkers were less likely to get COVID-19.

GSK, Vir ramping up U.S. output of COVID antibody drug
GSK, Vir ramping up U.S. output of COVID antibody drug
  • US
  • 2022-01-21 17:19:09Z

The U.S. government last week signed a deal with the drugmakers to buy 600,000 more doses of the therapy, sotrovimab, for an undisclosed sum. The GSK-Vir...

One chart shows how well vaccines and boosters protect against severe Omicron compared to Delta
One chart shows how well vaccines and boosters protect against severe Omicron compared to Delta

Booster shots appear to be at least 90% effective against hospitalization for both Delta and Omicron, new CDC data show.

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: US